Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Total 13F shares
-
63,950,445
-
Share change
-
-11,212,870
-
Total reported value
-
$77,407,916
-
Put/Call ratio
-
844%
-
Price per share
-
$1.21
-
Number of holders
-
83
-
Value change
-
-$23,984,627
-
Number of buys
-
44
-
Number of sells
-
55
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2024
As of 30 Jun 2024 Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) had 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 63,950,445 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Carlyle Group Inc., Aquilo Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and Blackstone Inc..
This table shows 83 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.